Section of Urology w 7-51 found a loop ureterostomy simple and effective. The use of a skin flap to hold the ureter up is better than the insertion of a glass rod as the ureter tends to retract once the rod is removed. The indications for temporary ureterostomy in a series of 11 patients were: Bladder tumour 2, megaureter 3, bladder neck obstruction 2, urethral valves 4. Our observations so far suggest that the grossly dilated ureters will take a very long time before they become smaller in spite of free drainage; cine-radiography carried out three months after the initial operation revealed dilated and quite inactive ureters. On the other hand the defunctioned bladder contracts especially if it was hypertrophied as in cases of urethral valves or bladder neck obstruction, and if re-anastomosis of the ureters is delayed too long a permanently small-capacity bladder will result. We have, therefore, tried to close these ureterostomies within four to six months.
The types of ureterostomy performed in this group were: Intubated in situ 2 (failed), terminal 2, loop 8 (one previously intubated). Although stickon bags can be fitted to collect the urine when so desired the ureterostomies can safely be covered by an ordinary napkin without fear of ulceration. We have experienced no undue difficulty in closing these ureterostomies by resection and end-to-end anastomosis at the same time -as carrying out definitive surgery for the urinary outflow obstruction.
The Topical Use of Cytotoxic Drugs for Bladder Cancer by H C Jones FRCS (Department of Urology, General Hospital, Newcastle-on-Tyne) This paper is a preliminary report on the treatment of bladder tumours by the intracavitary instillation of a cytotoxic drug.
One of the major problems in bladder tumour therapy is the patient with multiple papillary neoplasms. In the past intracavitary radioactive isotopes were used to treat cases of this type, but the incidence of post-irradiation change in the bladder was high and these techniques were abandoned. More recently super-voltage external irradiation has been used for this type of case and total cystectomy has been employed for extensive recurrences following radiotherapy.
In recent years alkylating agents have been used to treat malignant effusions by intracavitary instillation, and-these agents have largely replaced the use of radioactive isotopes for this purpose. This has led us to consider, the possibility of using one of these agents by direct instillation into the bladder for the treatment of bladder tumours of the types previously thought suitable for intracavitary irradiation. It was therefore decided to carry out clinical trials with the alkylating agent, thioTEPA, employing the intracavitary principle. Two types of tumour were treated in this way; multiple papillary tumours comprised the majority, and in a smaller number of infiltrating poorly differentiated tumours this method was used in an attempt to control haematuria when cystectomy was contraindicated. Before a specific regime was decided upon two factors required some consideration. The first was the possible effect of an alkylating agent on the normal bladder epithelium. ThioTEPA was selected for initial clinical trials because it was known to be a relatively non-toxic substance which could be injected into most normal tissues and body cavities with few local adverse effects. The normal bladder epithelium is composed of cells with a relatively low rate of mitotic division and it seemed unlikely that thioTEPA would have much effect upon it. Bateman (1955) had already reported the treatment of one patient with an advanced bladder carcinoma with intracavitary thioTEPA and no adverse effect on the bladder was observed.
The second problem was the possibility that some of the drug would be absorbed from the bladder, and in practice this has proved to be so, and has limited the total amount of the drug which we have been able to use.
Absorption of Chemical Substances from the Bladder The absorptive properties of the bladder were studied by Maluf (1953 Maluf ( , 1955 , who found that the bladder acts as a poorly permeable membrane, allowing the absorption of some chemical substances by a process of simple diffusion. He found that urea, water and sodium chloride were all absorbed to some extent from the bladder, and sodium iodide was absorbed from concentrated solutions in amounts sufficient to produce pyelograms. Glucose and glycine were not absorbed to a significant extent.
Yeates (1960, personal communication) studied the absorption of various sulphonamide preparations from the bladder. Sulphacetamide was absorbed and could be demonstrated in the blood, while sulphanilamide and sulphasolucin were not absorbed. Molecular size, therefore, determines absorption from the bladder and the substances absorbed have molecular weights of under 200.
The molecular weight of thioTEPA is 189 and it was therefore expected it would be absorbed. Using a chemical method ofestimation devised by Raine (1962) , it was shown that thioTEPA was absorbed from the bladder. In 2 patients first treated with this technique, a small total dose of 30 mg of thioTEPA in 100 ml sterile water was used, and the absorption of the drug estimated chemically. It was found that one-third of the thioTEPA had been absorbed and our future regime was based on the assumption that significant absorption of thioTEPA would occur.
Dose Regime
Initially doses of 30 mg in 50 ml of water were given and repeated on alternate days to a total dose of 120 mg; the amount given was increased to individual doses of 60, 90 and finally 120 mg, giving four doses on alternate days and rising initial concentrations of 1/500 in each case. At these high dose rates 2 patients did develop a fall in the total white cell count from absorption of the drug. In subsequent cases the dose was reduced to 45 mg, this amount being given on six occasions at weekly intervals, each dose being retained for three hours. With this regime there has been no marrow depression from absorbed drug.
Technique
A simple catheter technique is used for the administration of intracavitary thioTEPA. The treatment is carried out as an out-patient procedure. Prophylactic sulphamethizole is given to control infection; regular blood counts are done during treatment anid are continued for three weeks after treatment has ended.
Case Material
A total of 28 patients has been selected for this form of treatment. In 24 treatment was given for multiple papillary tumoulr with no clinical or histological evidence of infiltration. One patient with a large solitary papillary tumour was treated because a urethral stricture prevented the passage of a resectoscope. Histological examination of the tumours in these cases has shown a well-differentiated transitional cell carcinoma with no evidence of invasion. In addition 3 patients with large infiltrating tumours were treated in an attempt to control persistent hematuria. Histological examination of these tumours revealed a poorly differentiated infiltrating carcinoma in each.
Results
The effect on the bladder: There was no obvious disturbance of bladder function in 23 of the 28 patients. In 5 patients increased frequency and dysuria occurred during treatment.' In each of these cases there was an obvious urinary infection, with positive urinary culture, and these symptoms subsided rapidly following the administration of an appropriate antibiotic. The effect on the tumour: The effect on the tumour was found to vary. In the single large papillary tumour there was no obvious effect. In 4 of the cases of multiple papillomatosis there was no effect and in these patients the tumours were relatively large, being of the order of 1 to 2 cm in diameter. In 3 patients there was an incomplete response, the smaller tumours disappearing, leaving the more bulky tumours unaffected. In 17 patients a complete or almost complete disappearance of the tumours occurred, leaving only minute residual tumours which were easily destroyed by transurethral fulguration. Two patients required two separate courses of treatment to achieve complete clearance of tumour. It was found that in cases responding satisfactorily little change occurred for six weeks and the maximal response occurred after three months.*-There was no obvious difference in the histological appearances of the tumours responding and those not doing so.
Differences in dosage had no obvious effect on results, which were as satisfactory using six doses of 45 mg as with much larger amounts of drug.
The effect on hAwmaturia: In 3 patients with infiltrating neoplasms himaturia ceased following treatment in one case, was diminished in a second and in the third there was no response.
Conclusions
ThioTEPA when introduced into the bladder may cause the disappearance of certain kinds of papillary neoplasm. The method may have a place in the treatment of multiple small papillary tumours when the alternative would be a more radical form of treatment.-The method should be used with some caution in view of the systemic absorption which occurs.
